| Literature DB >> 33973152 |
Danyal Z Khan1,2, Ahmad M S Ali3, Chan Hee Koh1,2, Neil L Dorward1, Joan Grieve1, Hugo Layard Horsfall1,2, William Muirhead1,2, Thomas Santarius4, Wouter R Van Furth5, Amir H Zamanipoor Najafabadi5, Hani J Marcus6,7.
Abstract
PURPOSE: Postoperative cerebrospinal fluid rhinorrhoea (CSFR) remains a frequent complication of endonasal approaches to pituitary and skull base tumours. Watertight skull base reconstruction is important in preventing CSFR. We sought to systematically review the current literature of available skull base repair techniques.Entities:
Keywords: CSF; Cerebrospinal fluid; Cerebrospinal fluid leak; Cerebrospinal fluid rhinorrhoea; Endoscopic endonasal; Endoscopic transsphenoidal surgery; Skull base surgery
Mesh:
Year: 2021 PMID: 33973152 PMCID: PMC8416859 DOI: 10.1007/s11102-021-01145-4
Source DB: PubMed Journal: Pituitary ISSN: 1386-341X Impact factor: 4.107
Fig. 1PRISMA flow chart of paper identification, screening and eventual inclusion
Commonest pathologies treated using the transsphenoidal or expanded endonasal approach
| Most common pathology types | No. of studies |
|---|---|
| Pituitary adenoma | 156 |
| Rathke Cleft Cyst | 65 |
| Craniopharyngioma | 92 |
| Chordoma | 56 |
| Meningioma (e.g. planum sphenoidale, tuberculum sellae, clival, cavernous, olfactory groove) | 77 |
| Arachnoid cyst | 14 |
| Metastatic (e.g. breast, renal, melanoma) | 17 |
| Other cysts (epidermoid, dermoid, colloid, hydatid) | 14 |
Fig. 2Repair technique taxonomy
Fig. 3Sagittal section to the skull base highlighting various levels of repair and common repair techniques used per level
Overview of the repair technique characteristics within each anatomical level
| Purpose | Examples | Advantages | Disadvantages |
|---|---|---|---|
| Intradural | |||
| To obliterate excessive dead space (e.g. intrasellar) after tumour resection | • Autologous grafts (e.g. fat) • Synthetic grafts (e.g. collagen sponge, gelatine sponge) | • Provides support to surrounding neurovascular structures (e.g. optic chiasm) • Absorbs CSF pulsations (if fluctuant) | • Risk of overpacking causing and damage to surrounding structures (e.g. optic apparatus compression) • Risk of obstructive hydrocephalus if particulate entry into ventricular system (e.g. an open third ventricle) • Premature absorption (fat grafts) • Potential interference with postoperative MRI interpretation • Autologous grafts: donor-site morbidity • Synthetic grafts: increased direct cost, decreased biocompatibility, infection |
| Dural | |||
| To repair the dural defect—via primary closure or reconstruction | • Dural sutures • Dural clips • Autologous grafts (e.g. fascia lata) • Allografts and xenografts (e.g. cadaveric fascia) • Synthetic grafts (e.g. artificial dura) | • Potential for watertight seal | • Sutures/clips: technically challenging, time-consuming nature, steep learning curves, limited to small defects unless grafts used in patchwork fashion, radiological artefacts (clips) • Autologous grafts: donor-site morbidity • Allografts and xenografts: donor infection transmission • Synthetic grafts: increased direct cost, decreased biocompatibility, infection |
| Bony | |||
| To repair the bony skull base (e.g. sellar floor) using rigid or semi-rigid grafts | • Autologous grafts (e.g. nasal bone) • Allografts and xenografts (e.g. cadaveric iliac crest) • Synthetic grafts (e.g. Medpor) | • Capable of withstanding higher forces across the repair site and provides protection to underlying structures | • Autologous grafts: donor-site morbidity • Allografts and xenografts: donor infection transmission • Synthetic grafts: increased direct cost, decreased biocompatibility, infection, radiological artefacts |
| Nasal | |||
| Direct reconstruction of skull base (vascular flaps) or support to underlying repair (buttresses and nasal packing) | • Pedicled flap • Autologous buttress • Synthetic buttress • Nasal packing | • Vascularised repairs have the potential to maintain supportive strength for a long period of time and adhere strongly to the skull base • Packing and buttressing may protect the underlying repair from force across the repair site | • Vascular flaps: donor site morbidity (e.g. nasal crusting) • Autologous buttress: donor site morbidity • Synthetic buttress: increased direct cost, decreased biocompatibility, infection, extrusion, chronic sphenoid sinusitis, radiological artefacts • Packing: discomfort, risk of dislodgement, risk of adhesion to underlying repair |
| CSF diversion | |||
| Reduction of CSF pressure and pulsations to support reconstruction | • Short-term (e.g. lumbar drain) • Long-term (e.g. ventriculoperitoneal shunt) | • Supported by level 1B evidence (peri-operative lumbar drainage) | • Low-pressure headaches, pneumocephalus, infection, neural injury, bleeding, catheter dislodgment, retained catheter, increased length of stay, decreased mobility, venous thromboembolism, anaesthetic complications |
CSF cerebrospinal fluid, MRI magnetic resonance imaging
The rates and methods of confirmation and management of intraoperative CSF leak and postoperative CSF rhinorrhoea
| Measure | Transsphenoidal approach | Expanded endonasal approach | Both approaches |
|---|---|---|---|
| Intraoperative CSF leak | |||
| No. of studies reporting | 87/95 (92%) | 53/55 (97%) | 32/43 (82%) |
| Methods of confirmation (number of studies) | Valsalva (n = 32) IT fluorescein (n = 6) Observation alone (n = 2) IT saline (n = 1) Not specified (n = 54) | Valsalva (n = 3) IT fluorescein (n = 5) Observation alone (n = 2) Not specified (n = 45) | Valsalva (n = 12) IT fluorescein (n = 4) Observation alone (n = 2) Not specified (n = 25) |
| Grading methods (number of studies) | Esposito-Kelly (n = 15) High/low flow (n = 13) Modified Esposito-Kelly (n = 1) Anatomical grading (n = 2) Not specified (n = 64) | Esposito-Kelly (n = 4) High/low flow (n = 12) Not specified (n = 43) | Esposito-Kelly (n = 13) High/low flow (n = 12) Modified Esposito-Kelly (n = 2) Not specified (n = 16) |
| Postoperative CSF rhinorrhea | |||
| No. of studies reporting | 94/95 (99%) | 55/55 (100%) | 41/43 (95%) |
| Adjuncts for confirmation (number of studies) | β2 transferrin (n = 10) tes-tape (n = 1) Not specified (n = 84) | Pneumocephalus on CT (n = 2) β2 transferrin (n = 3) Not specified (n = 50) | β2 transferrin (n = 4) Pneumocephalus on CT (n = 5) MRI (n = 3) Leaning forward (n = 4) Tch99 cisternography (n = 1) IT fluorescein (n = 1) Endoscopic exploration (n = 2) Not specified (n = 23 |
| CSFR management methods (number of studies) | Lumbar drain (n = 28) Reoperation (n = 46) VPS (n = 2) Combined lumbar drain and reoperation (n = 17) Serial lumbar punctures (n = 1) Not specified (n = 1) | Lumbar drain (n = 18) Reoperation (n = 30) VPS (n = 3) EVD (n = 1) Not specified (n = 3) | Lumbar drain (n = 15) Reoperation (n = 24) Combined lumbar drain and reoperation (n = 4) Not specified (n = 8) |
IT intrathecal, Tch technetium, CSF cerebrospinal fluid, MRI magnetic resonance imaging, CT computed topography, VPS ventriculo-peritoneal shunt, EVD external ventricualr drain